Pure Global AI
NCT06331338Recruiting

Effects of Using Decision Cycle for Person-Centered Glycemic Management in Type 2 Diabetes

Research on the Effectiveness of Using Decision Cycle for Person-Centered Glycemic Management on Self-Care Behaviors in Outpatients With Type 2 Diabetes
National Taiwan University HospitalClinicalTrials.govbehavioral
Verified
Study focus
Disease/Condition
Type 2 Diabetes
Drug/Device/Intervention
Decision Cycle for Person-Centered Glycemic Management
Study type
Interventional
Intervention type
behavioral
Sponsor & location
Primary sponsor
National Taiwan University Hospital
Location
Hsinchu, Taiwan
Timeline & enrollment
Phase
N/A
Start date
Feb 14, 2024
End date
Dec 31, 2025
Enrollment
130 participants
Primary outcome

glycemic control (HbA1c)

Summary

Decision cycle for person-centered glycemic management is a new diabetes decision making .It
 is defined as a purposefully designed holistic care intervention .The goal is to improve the
 self-care behavior of patients with type 2 diabetes, thereby improving glycated hemoglobin
 levels and delaying the occurrence of complications.

ICD-10 classifications
Type 2 diabetes mellitusType 2 diabetes mellitus without complicationsType 2 diabetes mellitus with unspecified complicationsType 2 diabetes mellitus with other specified complicationsType 2 diabetes mellitus with multiple complications
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06331338
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06331338 through Pure Global AI's free database. This phase not specified trial is sponsored by National Taiwan University Hospital and is currently Recruiting. The study focuses on Type 2 Diabetes. Target enrollment is 130 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.